کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2019539 1542211 2015 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Antiplatelet drug resistance: Molecular insights and clinical implications
ترجمه فارسی عنوان
مقاومت به دارو ضدالتهاب: بینش مولکولی و پیامدهای بالینی
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی زیست شیمی
چکیده انگلیسی


• Antiplatelet drug resistance confers an increased cardiovascular risk.
• There is no validated approach to identify and treat these individuals.
• Molecular insights may translate to improved clinical outcomes.

Antiplatelet drugs are prescribed to patients with cardiovascular disease in order to reduce their risk of clinically important atherothrombotic events. However, a proportion of patients fail to appropriately respond to these drugs in a heterogeneous phenomenon known as ‘antiplatelet drug resistance’. Individuals who are identified as being resistant have a higher cardiovascular risk, but currently there is no clinically validated approach to identify and treat these individuals. Large randomised control trials have attempted to personalise antiplatelet therapy based on platelet function testing, but these have failed to demonstrate improved clinical outcomes. An alternative approach to this non-specific assessment of platelet function is to consider whether antiplatelet therapy may be personalised based on the identification of molecular mechanisms that are known to confer resistance. Here we present molecular insights into the mechanisms for aspirin and clopidogrel resistance, with a discussion of their clinical implications.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Prostaglandins & Other Lipid Mediators - Volume 120, July 2015, Pages 21–27
نویسندگان
, ,